112 related articles for article (PubMed ID: 1847490)
1. 14, 15-cis-episulfide-eicosatrienoic acid, an 'epoxygenase' eicosanoid analog, inhibits ionophore- but not thrombin-induced platelet aggregation.
Bernstrom K; Malcolm K; McGee J; Maclouf J; Levy-Toledano S; Falck JR; Fitzpatrick FA
Mol Pharmacol; 1991 Feb; 39(2):114-9. PubMed ID: 1847490
[TBL] [Abstract][Full Text] [Related]
2. 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets.
Wu CC; Wang TW; Wang WY; Hsieh PW; Wu YC
Eur J Pharmacol; 2005 Dec; 527(1-3):37-43. PubMed ID: 16313903
[TBL] [Abstract][Full Text] [Related]
3. Novel eicosanoids generated by cytochrome P450: effects on platelet aggregation and protein phosphorylation.
Malcolm K; Falck JR; Fitzpatrick FA
Adv Prostaglandin Thromboxane Leukot Res; 1990; 20():87-94. PubMed ID: 2144702
[No Abstract] [Full Text] [Related]
4. Effects of DK-002, a synthesized (6aS,cis)-9,10-Dimethoxy-7,11b-dihydro-indeno[2,1-c]chromene-3,6a-diol, on platelet activity.
Lee KS; Khil LY; Chae SH; Kim D; Lee BH; Hwang GS; Moon CH; Chang TS; Moon CK
Life Sci; 2006 Feb; 78(10):1091-7. PubMed ID: 16153663
[TBL] [Abstract][Full Text] [Related]
5. Effect of the polyamine-spermine on agonist-induced human platelet activation--specific inhibition of "aggregation-independent" events induced by thrombin, but not by collagen, thromboxane mimetic, phorbol ester or calcium ionophore.
Joseph S; Krishnamurthi S; Kakkar VV
Thromb Haemost; 1987 Apr; 57(2):191-5. PubMed ID: 3110996
[TBL] [Abstract][Full Text] [Related]
6. Diacylglycerol overcomes aspirin inhibition of platelets: evidence for a necessary role for diacylglycerol accumulation in platelet activation.
Werner MH; Senzel L; Bielawska A; Khan W; Hannun YA
Mol Pharmacol; 1991 Apr; 39(4):547-56. PubMed ID: 2017154
[TBL] [Abstract][Full Text] [Related]
7. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation.
Rotondo S; Krauze-Brzósko K; Manarini S; Evangelista V; Cerletti C
Eur J Pharmacol; 2004 Mar; 488(1-3):79-83. PubMed ID: 15044038
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of GBH on platelet aggregation through inhibition of intracellular Ca2+ mobilization in activated human platelets.
Park WH; Kim HK; Nam KS; Shon YH; Jeon BH; Moon SK; Kim MG; Kim CH
Life Sci; 2004 Nov; 75(25):3063-76. PubMed ID: 15474558
[TBL] [Abstract][Full Text] [Related]
9. Phenothiazine compounds enhance phentolamine effects on platelet aggregation and thromboxane B2 production.
Anfossi G; Trovati M; Mularoni E; Massucco P; Cavalot F; Mattiello L; Emanuelli G
Arch Int Pharmacodyn Ther; 1990; 307():142-61. PubMed ID: 1982777
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of platelet thromboxane formation and phosphoinositides breakdown by osthole from Angelica pubescens.
Ko FN; Wu TS; Liou MJ; Huang TF; Teng CM
Thromb Haemost; 1989 Nov; 62(3):996-9. PubMed ID: 2556815
[TBL] [Abstract][Full Text] [Related]
11. Influence of phentolamine on platelet aggregation, thromboxane B2 production and release reaction.
Anfossi G; Trovati M; Mularoni E; Lanzio M; Massucco P; Emanuelli G
Arch Int Pharmacodyn Ther; 1988; 296():144-54. PubMed ID: 2853612
[TBL] [Abstract][Full Text] [Related]
12. Effects of dilazep on cytoplasmic calcium ion concentrations and arachidonic acid metabolism in activated human platelets.
Okuma M; Kanaji K; Sensaki S; Uchino H
Arzneimittelforschung; 1989 Mar; 39(3):372-5. PubMed ID: 2502990
[TBL] [Abstract][Full Text] [Related]
13. Verapamil and collagen-induced platelet reactions--evidence for a role for intracellular calcium in platelet activation.
Han P; Boatwright C; Ardlie NG
Thromb Haemost; 1983 Aug; 50(2):537-40. PubMed ID: 6415847
[TBL] [Abstract][Full Text] [Related]
14. Effect of the calcium-entry blocking agent nifedipine on activation of human platelets and comparison with verapamil.
Han P; Boatwright C; Ardlie NG
Thromb Haemost; 1983 Aug; 50(2):513-7. PubMed ID: 6314581
[TBL] [Abstract][Full Text] [Related]
15. Evidence that KF4939, a new anti-platelet agent, inhibits phospholipase activation in rabbit platelets: different aspects from cyclic AMP increasing agents and calmodulin antagonist.
Yamada K; Shuto K; Kubo K; Nakamizo N
Arch Int Pharmacodyn Ther; 1984 Mar; 268(1):141-54. PubMed ID: 6329114
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of platelet function by polymorphonuclear leukocytes.
Zatta A; Prosdocimi M; Bertelé V; Bazzoni G; Del Maschio A
J Lab Clin Med; 1990 Nov; 116(5):651-60. PubMed ID: 2146349
[TBL] [Abstract][Full Text] [Related]
17. [The studies on the mechanism of platelet activation induced by exogenous arachidonic acid with special reference to intraplatelet Ca2+ mobilization].
Koyama M
Hokkaido Igaku Zasshi; 1994 Jul; 69(4):1044-56. PubMed ID: 7959585
[TBL] [Abstract][Full Text] [Related]
18. Megakaryocyte thromboxane production induced by platelet stimuli during in vitro culture.
Walenga RW; Miller JL; Stuart MJ
Exp Hematol; 1985 Feb; 13(2):87-91. PubMed ID: 3918879
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of antiplatelet activity of PC-09, a newly synthesized pyridazinone derivative.
Cherng SC; Huang WH; Shiau CY; Lee AR; Chou TC
Eur J Pharmacol; 2006 Feb; 532(1-2):32-7. PubMed ID: 16457809
[TBL] [Abstract][Full Text] [Related]
20. Indirect actions of thapsigargin on human platelets: activation of eicosanoid biosynthesis and cellular signaling pathways.
Malcolm KC; Fitzpatrick FA
J Pharmacol Exp Ther; 1992 Mar; 260(3):1244-9. PubMed ID: 1532033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
